Marc Odrich
Fortuna: 779 572 $ al 31/05/2026
Fortuna: 779 572 $ al 31/05/2026
Marc Odrich is currently Chief Medical Officer & Director at TearSolutions, Inc., Director at CXL Ophthalmics LLC, Associate Professor at the University of Virginia, and Chief Medical Officer at LENZ Therapeutics, Inc. Formerly, Dr. Odrich was Medical Director at VISX, Inc. Education includes a doctorate from Columbia University College of Physicians & Surgeons.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
0,32 % | 14/04/2026 | 100.202 ( 0,32 % ) | 779 572 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
TearSolutions, Inc.
TearSolutions, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural tear generation therapy for dry eyes | Corporate Officer/Principal | - |
CXL Ophthalmics LLC
CXL Ophthalmics LLC Medical/Nursing ServicesHealth Services Develops a treatment for eyecare | Director/Miembro de la Junta | - |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
VISX, Inc. | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University College of Physicians & Surgeons
Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TearSolutions, Inc.
TearSolutions, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural tear generation therapy for dry eyes | Health Technology |
VISX, Inc. | |
CXL Ophthalmics LLC
CXL Ophthalmics LLC Medical/Nursing ServicesHealth Services Develops a treatment for eyecare | Health Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.